Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

56
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
56
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

43
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
43
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.1K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.1K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

56
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
56
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

2.2K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.2K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

623
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
623

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the Rotisserie: Dispelling the Myths of Intravesical Therapy and Pioneering a Precision Future for Bladder Cancer.

Urology research & practice·2026
Same author

Novel 30-amp MOSES versus MOSES 2.0 pulse-modulation technologies for holmium laser enucleation of the prostate (HoLEP).

World journal of urology·2026
Same author

A Comparative Study on the Influence of Zirconia and Titanium Nanoparticles on the Functionality of Osteocytes In Vitro.

International journal of dentistry·2026
Same author

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.

International urology and nephrology·2026
Same author

Systemic flavonoid exposure and NF-κB mediated suppression of Th2 responses by Ziziphus spina-christi attenuate HDM-induced allergic asthma.

Journal of ethnopharmacology·2026
Same author

Comparative study between PET-CT simulation and CT for head and neck cancer treatment and their potential effect on the thyroid gland: a prospective comparative study.

Radiation oncology (London, England)·2026

Related Experiment Video

Updated: Sep 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

13.9K

Aristolochic acid: What urologists should know.

Mohanarangam Thangavelu1, Asmaa Ismail2, Ahmed Zakaria3

  • 1Northern Ontario School of Medicine, Thunder Bay, Ontario. drtmohan@googlemail.com.

Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|March 30, 2022
PubMed
Summary

Aristolochic acid is a significant cause of upper tract urothelial carcinoma, particularly in younger individuals. This letter aims to clarify information about this toxin for urologists to better understand its adverse effects on patients.

More Related Videos

Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
03:37

Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats

Published on: October 11, 2024

481
In Vivo Luminal Measurement of Distension-Evoked Urothelial ATP Release in Rodents
09:17

In Vivo Luminal Measurement of Distension-Evoked Urothelial ATP Release in Rodents

Published on: September 7, 2022

1.7K

Related Experiment Videos

Last Updated: Sep 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

13.9K
Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
03:37

Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats

Published on: October 11, 2024

481
In Vivo Luminal Measurement of Distension-Evoked Urothelial ATP Release in Rodents
09:17

In Vivo Luminal Measurement of Distension-Evoked Urothelial ATP Release in Rodents

Published on: September 7, 2022

1.7K

Area of Science:

  • Toxicology
  • Urology
  • Oncology

Background:

  • Aristolochic acid is a known etiological factor for upper tract urothelial carcinoma (UTUC).
  • Despite its recognition in clinical guidelines, detailed knowledge of aristolochic acid among urologists remains limited.
  • Understanding the toxin is crucial for managing UTUC, especially in younger patients.

Purpose of the Study:

  • To provide urologists with clear and direct information regarding aristolochic acid.
  • To enhance the understanding of how aristolochic acid adversely affects patients with UTUC.
  • To bridge the knowledge gap concerning this specific toxin in clinical practice.

Main Methods:

  • Literature review and synthesis of existing data on aristolochic acid.
  • Focus on toxicological mechanisms and clinical manifestations.
  • Information compilation for educational purposes.

Main Results:

  • Aristolochic acid is a potent nephrotoxin and carcinogen.
  • It is implicated in a subset of UTUC cases, often presenting in younger demographics.
  • Mechanisms of action involve DNA adduct formation and subsequent mutations.

Conclusions:

  • Increased awareness and knowledge of aristolochic acid are necessary for urologists.
  • This understanding can lead to improved patient diagnosis and management strategies for UTUC.
  • Further research into the long-term effects and specific patient populations affected is warranted.